Lung Cancer Liquid Biopsy Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024

  • Published: Oct 2020
  • Pages: 120
  • SKU: IRTNTR45510
Technavio

The 2021-2025 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The lung cancer liquid biopsy market size will record an incremental growth of $ 292.89 mn and a CAGR of 16% during 2020-2024.

This market report entails segmentation by product (CTCs and ctDNA and Exosomes and RNA) and geography (North America, Europe, Asia, and ROW). View our sample report to gather market insights on the segmentations. 

The lung cancer liquid biopsy market report also analyzes the market’s competitive landscape and offers information on several market vendors, including Biocartis Group NV, Biocept Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., QIAGEN NV, Sysmex Corp., Thermo Fisher Scientific Inc., and Trovagene Inc..

What will the Lung Cancer Liquid Biopsy Market Size be in 2020?

View the TOC and LoE with selected illustrations and example pages of lung cancer liquid biopsy market

Request a FREE sample now!

Overview of Competitive Analysis

The lung cancer liquid biopsy market forecast report provides insights on complete key vendor profiles and their business strategies to reimage themselves. The profiles include information on the production, competitive landscape, sustainability, and prospects of the leading companies.

The market structure is fragmented. With the shift in consumer behavior owing to the COVID-19 pandemic, the vendors are focusing on leveraging upcoming trends and drivers that have been identified and explored in this lung cancer liquid biopsy market analysis report. Factors such as the Rising incidence of lung cancer | Increasing participation in conferences to endorse the products | Technologically advanced products will offer immense growth opportunities. The report also covers challenges and strategies to dodge them, which will help vendors in recreating their plan of action to obtain growth opportunities in the future.

To make the most of the opportunities, vendors should also capitalize on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Fetch actionable market insights on post-COVID-19 impact on each product and service segments.

Which are the Key Regional Markets for Lung Cancer Liquid Biopsy Market?

For more lung cancer liquid biopsy market insights of various regions Request a FREE sample now!

The report offers an up-to-date analysis of the geographical composition of the market. North America had the largest market share in the lung cancer liquid biopsy market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The Growing partnership agreements | Application of liquid biopsy for personalized treatment will significantly influence lung cancer liquid biopsy market growth in this region. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report

49% of the market’s growth will originate from North America during the forecast period. US | Germany | France | UK | Japan | China are the key markets for lung cancer liquid biopsy market in the region. This report provides estimations of the contribution of all regions to the growth of the lung cancer liquid biopsy market size.

Event-Tickets-Market-Report

Request for a FREE sample

What are the Key Factors Covered in this Lung Cancer Liquid Biopsy Market Report?

  • CAGR of the market during the forecast period 
  • Detailed information on factors that will drive lung cancer liquid biopsy market growth during the next five years
  • Precise estimation of the size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the lung cancer liquid biopsy market industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of lung cancer liquid biopsy market vendors

Need a Customized Report? Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The lung cancer liquid biopsy market growth will increase by $292.89 million during 2019-2024.
The lung cancer liquid biopsy market is expected to grow at a CAGR of 16.32% during 2019-2024.
Technavio has segmented the lung cancer liquid biopsy market by product (CTCs and ctDNA and Exosomes and RNA) ,end user (Clinical diagnostic laboratories and Hospitals and clinics) , and geographic (North America, Europe, Asia, and ROW).
Biocartis Group NV, Biocept Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., QIAGEN NV, Sysmex Corp., Thermo Fisher Scientific Inc., Trovagene Inc. are a few of the key vendors in the lung cancer liquid biopsy market.
North America will register the highest growth rate of 49.28% among the other regions. Therefore, the lung cancer liquid biopsy market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the lung cancer liquid biopsy market growth are:
  • Rising incidence of lung cancer
  • Growing partnership agreements
The lung cancer liquid biopsy market vendors should focus on grabbing business opportunities from the ctcs and ctdna segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase

Technavio's SUBSCRIPTION platform

Register for a free trial today and gain instant access to 17,000+ market research reports.

START YOUR FREE TRIAL

Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>